Bio Green Energy Tech PCL (BIOTEC) fair value: what the stock is really worth
As of Nov 9, 2026: fair value (intrinsic value) of Bio Green Energy Tech PCL stock THB 0.23, price THB 0.27, that is 14.8% below the price, quality 63 out of 100. Rating: overvalued. Calculated from audited financials with 20 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 7, 2026.
How to read this chart
60‑month range 0.1600 THB – 1.57 THB · fair‑value band 0.2300 THB – 0.2400 THB · the 0.2700 THB price screens above the 0.2300 THB fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 7, 2026.
Follow Bio Green Energy Tech PCL in your weekly email
Every Wednesday you see whether Bio Green Energy Tech PCL is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Bio Green Energy Tech Public Company Limited, together with its subsidiaries, engages in the marine transportation business in Thailand and internationally.
Show moreShow less
The company offers boat charter, ship management, seafarer management, cargo handling, ship repair and maintenance, ship representation, and ship trading services. It also manufactures and distributes biodiesel glycerine products.
The company was formerly known as Jutha Maritime Public Company Limited and changed its name to Bio Green Energy Tech Public Company Limited in May 2022. Bio Green Energy Tech Public Company Limited was founded in 1976 and is headquartered in Bangkok, Thailand.
Stock analysis
Bio Green Energy Tech PCL (BIOTEC) currently trades at 0.2700 THB, while our model-based Fair Value estimate is 0.2300 THB, 15% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of 0.4400 THB per share, and 10 of the 19 models we run sit above the 0.2700 THB price.
Bear case: the Earnings-Based group reads lowest at 0.0800 THB, and 9 of the 19 models stay below the price. Data coverage for this calculation is low.
Scenario range: 0.2300 THB (bear) to 0.2400 THB (bull), the price of 0.2700 THB sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 63/100 (solid quality), in the Basic Materials sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Bio Green Energy Tech PCL reported revenue of 4.2B THB in FY2025 versus 323M THB in FY2021, a compound +89.9%/yr. Reported net income was 29.3M THB in FY2025, compounding −11.0%/yr from FY2021.
Key figures
Market cap 824M THB (≈ $24.6M) Micro · P/E ratio 4.5 · P/S ratio 0.18 · EPS (TTM) 0.0600 THB · Net margin 4.1% · Return on equity 16.5% · Return on assets (EBIT) 1.1% (5-year average) · Operating margin 5.7%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 40 out of 100 (low confidence).
What moves the price
The share trades about 23% below its 52-week high and 59% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −43% fair-value upside, at −15%, BIOTEC screens cheaper than that median.
Fair Value models
Bear0.2300 THBFair Value 0.2300 THBBull0.2400 THB
Price 0.2700 THB · Downside -14.8%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (0.0515 THB per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.84/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−7.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−1.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+82.8%
Start year 2020 (pandemic). Over 10 years: +26.6% a year
Revenue growth 19 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.1%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in THB ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in THB: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−38.7%
Earnings growth per share plus dividend.
Earnings per share, growth per year−38.7%
Dividend (yield on the price)0.0%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−53% → 1%
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−7.1%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Thailand: IMF forecast 1.2% a year to 2030, 1.1% from 2016 to 2025) that is about −8.2% a year for the price.
Compare Bio Green Energy Tech PCL with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 728 stocks
Beats the industry median on 10/14 measures
Overall it ranks above its industry peers.
Valuation
Quality Score63 · Top 25%
Fair Value upside−11.5% · Above median
Profitability
Return on equity (12 months)16.5% · Top 25%
Return on assets1.3% · Below median
Net margin (12 months)4.1% · Below median
Operating margin (12 months)5.7% · Below median
Growth and dividend
Revenue growth (quarter YoY)55.2% · Top 25%
Balance sheet
Debt / equity0.22× · Above median
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Bio Green Energy Tech PCL Fair Value". https://www.fairvalue-calculator.com/stock/BIOTEC
Frequently asked questions
Is Bio Green Energy Tech PCL (BIOTEC) overvalued or undervalued?
As of Nov 7, 2026, our model estimates a fair value of 0.2300 THB versus a price of 0.2700 THB, about 15% lower (overvalued).
What is the fair value of BIOTEC?
Our model-based fair value for Bio Green Energy Tech PCL is 0.2300 THB (as of Nov 7, 2026), built from audited fundamentals. The current price: 0.2700 THB.
What is the quality score of BIOTEC?
Bio Green Energy Tech PCL has a Quality Score of 63/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Bio Green Energy Tech PCL (BIOTEC)?
Our model-based price target is the fair value of 0.2300 THB (as of Nov 7, 2026) from 20 valuation models. Cautious scenario 0.2300 THB, optimistic scenario 0.2400 THB. It is a calculation from audited fundamentals, not an analyst target.
What is the Bio Green Energy Tech PCL stock forecast for 2026?
Our models put fair value at 0.2300 THB, about 15% lower versus a price of 0.2700 THB (overvalued). Cautious scenario 0.2300 THB, optimistic scenario 0.2400 THB. The calculation is refreshed regularly with new filings.
What is the revenue of Bio Green Energy Tech PCL (BIOTEC)?
Bio Green Energy Tech PCL reported trailing-twelve-month revenue of about 4.5B THB (latest available figure, as of Nov 7, 2026).
What growth is priced into Bio Green Energy Tech PCL (BIOTEC)?
For today's price to be fair in a discounted-cash-flow model, Bio Green Energy Tech PCL would have to grow free cash flow by -7.1 % per year for five years (discount rate 11.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +82.8 % per year. As of Nov 7, 2026.
What discount rate (WACC) does the fair value of BIOTEC use?
Our models discount Bio Green Energy Tech PCL at 11.6 %: a base by market capitalisation (nano), country premium for Thailand. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Bio Green Energy Tech PCL that is -7.1 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (11.6 %) and the same formula as our fair value.
How much growth has Bio Green Energy Tech PCL (BIOTEC) delivered so far?
Over the past 5 years revenue at Bio Green Energy Tech PCL grew +82.8 % a year. The price currently implies free-cash-flow growth of -7.1 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Bio Green Energy Tech PCL (BIOTEC) growing?
The median revenue growth in the sector is +9.8 % a year. That is the yardstick for the growth priced into Bio Green Energy Tech PCL (-7.1 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Bio Green Energy Tech PCL (BIOTEC)?
The free-cash-flow yield on the price is 21.56 %: that much free cash flow Bio Green Energy Tech PCL produces per unit of market value. When it exceeds the discount rate of our models (11.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Bio Green Energy Tech PCL (BIOTEC)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Bio Green Energy Tech PCL it is 0.2300 THB per share (as of Nov 7, 2026), against a price of 0.2700 THB. It is the blended result of 20 valuation models in 7 families (DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Bio Green Energy Tech PCL stock overvalued or undervalued in 2026?
As of Nov 7, 2026, BIOTEC trades above its calculated fair value: price 0.2700 THB, fair value 0.2300 THB, a gap of about −15% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of BIOTEC?
No. The price is what the market pays today (0.2700 THB); the fair value is what the company's own numbers justify (0.2300 THB). For Bio Green Energy Tech PCL the two are 0.0400 THB per share apart. That gap is exactly why we show both numbers side by side.
How much is Bio Green Energy Tech PCL worth?
The market values Bio Green Energy Tech PCL at about 824M THB (market capitalisation, as of Nov 7, 2026). Per share that is 0.2700 THB; our models calculate a fair value of 0.2300 THB per share.
What do the bullish and bearish scenarios say about BIOTEC?
Our models span a range for Bio Green Energy Tech PCL: cautious scenario 0.2300 THB, base 0.2300 THB, optimistic 0.2400 THB per share (as of Nov 7, 2026, price 0.2700 THB). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of BIOTEC?
Bio Green Energy Tech PCL trades at a price-to-earnings ratio of 4.5 (as of Nov 7, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 0.2300 THB is built from several models across several years. Other multiples: PEG 0.5, P/B 0.8, P/S 0.2, EV/EBITDA 4.3.
What is the PEG ratio of BIOTEC?
The PEG ratio of Bio Green Energy Tech PCL is 0.48 (P/E divided by earnings growth, as of Nov 7, 2026). That is below 1, so growth is priced more cheaply than the earnings multiple alone suggests.
How solid is the balance sheet of Bio Green Energy Tech PCL (BIOTEC)?
Balance-sheet figures for Bio Green Energy Tech PCL (as of Nov 7, 2026): return on equity 16.5%, debt of 0.22 per unit of equity. They feed the Quality Score of 63/100, which measures business quality independently of the share price.
How far is BIOTEC from its 52-week high?
Bio Green Energy Tech PCL trades at 0.2700 THB, about 23% below its 52-week high of 0.3500 THB and 59% above the low of 0.1700 THB (as of Nov 9, 2026). Distance from the high says nothing about value: that is what the fair value of 0.2300 THB is for.
Which stocks are comparable to Bio Green Energy Tech PCL?
From the same area (Basic Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Nan Ya Plastics Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Bio Green Energy Tech PCL stock attractive at the current price?
The data as of Nov 7, 2026: price 0.2700 THB, calculated fair value 0.2300 THB (−15%), Quality Score 63/100, from 20 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of BIOTEC calculated?
We run Bio Green Energy Tech PCL through 20 models from 7 families: DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 0.2300 THB builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Bio Green Energy Tech PCL itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Bio Green Energy Tech PCL (BIOTEC)?
The closing price on Nov 9, 2026 was 0.2700 THB. Our model-based fair value is 0.2300 THB, about 15% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Bio Green Energy Tech PCL right now?
The price sits above even our optimistic bull case (0.2400 THB). The favourable scenario is already priced in. Solid but not exceptional quality (63/100) and above fair value, neither a clear bargain nor a standout compounder. The models converge in a tight band (0.2300 THB to 0.2400 THB), unusually little disagreement for a valuation. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Bio Green Energy Tech PCL
How large is the market capitalisation of Bio Green Energy Tech PCL (BIOTEC)?
The market capitalisation of Bio Green Energy Tech PCL is 824M THB (≈ $24.6M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Bio Green Energy Tech PCL (BIOTEC)?
The price-to-sales ratio of Bio Green Energy Tech PCL is 0.18 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Bio Green Energy Tech PCL (BIOTEC)?
Earnings per share at Bio Green Energy Tech PCL are 0.0600 THB (price ÷ EPS = P/E 4.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Bio Green Energy Tech PCL (BIOTEC)?
The net margin of Bio Green Energy Tech PCL is 4.1% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Bio Green Energy Tech PCL (BIOTEC)?
The return on equity (ROE) of Bio Green Energy Tech PCL is 16.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Bio Green Energy Tech PCL (BIOTEC)?
On an EBIT basis the return on assets of Bio Green Energy Tech PCL is 1.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Bio Green Energy Tech PCL (BIOTEC)?
The operating margin of Bio Green Energy Tech PCL is 5.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Bio Green Energy Tech PCL (BIOTEC)?
Revenue at Bio Green Energy Tech PCL is growing +55.2% versus a year earlier (3y avg −1.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Bio Green Energy Tech PCL (BIOTEC)?
Earnings per share at Bio Green Energy Tech PCL are growing −92.5% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Bio Green Energy Tech PCL (BIOTEC) carry?
The net debt of Bio Green Energy Tech PCL is 350M THB (fiscal year 2025, ≈ 2.0 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Bio Green Energy Tech PCL in the live analysis
One click puts Bio Green Energy Tech PCL on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 7, 2026